Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Laboratorios Farmaceuticos ROVI SA
F:41L
Laboratorios Farmaceuticos ROVI SA
F:41L
Price:
59.2
EUR
1.89%
Market Cap:
€3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Laboratorios Farmaceuticos ROVI SA
F:41L
|
ES |
|
Fomento de Construcciones y Contratas SA
F:FCC0
|
ES |
|
O
|
OMV AG
XMUN:OMV
|
AT |
|
A
|
Asia Green Energy PCL
SET:AGE
|
TH |
|
A
|
Autozone Inc
SWB:AZ5
|
US |
|
C
|
Clinuvel Pharmaceuticals Ltd
XMUN:UR9
|
AU |
|
Bilfinger Se
F:GBFU
|
DE |
|
C
|
Canon Inc
F:CNN1
|
JP |
|
Diablo Resources Ltd
OTC:DBORF
|
AU |
|
I
|
Investec PLC
XMUN:IVKA
|
UK |
|
S
|
Sony Group Corp
XMUN:SON1
|
JP |
|
K
|
Komatsu Ltd
XMUN:KOM1
|
JP |
|
Entergy Corp
NYSE:ETR
|
US |
|
BMTC Group Inc
TSX:GBT
|
CA |
|
D
|
Dinero Ventures Ltd
XTSX:DNO
|
CA |
|
Kontrol Technologies Corp
F:1K8
|
CA |
|
Bpm Minerals Ltd
ASX:BPM
|
AU |
|
A
|
Appian Corp
F:910
|
US |
Wall St Price Targets
41L Price Forecast
Based on 13 analysts
Based on 13 analysts
+46% Upside
from
€59.2
today
Laboratorios Farmaceuticos ROVI SA (41L)’s 12-month stock price forecast through October 2027 has a consensus target of €86.68, implying 46% upside. The forecast is based on price targets from 13 Wall Street analysts.
41L Analyst Rating
No ratings yet
No ratings yet
Laboratorios Farmaceuticos ROVI SA Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 41L's stock price target?
Price Target
86.68
EUR
86.68
EUR
According to Wall Street analysts, the average 1-year price target for 41L is 86.68 EUR with a low forecast of 72.98 EUR and a high forecast of 101.16 EUR.
What is the Revenue forecast for Laboratorios Farmaceuticos ROVI SA?
Projected CAGR
9%
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 5 years is 9%.
What is the Gross Profit forecast for Laboratorios Farmaceuticos ROVI SA?
Projected CAGR
12%
12%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 5 years is 12%.
What is the Operating Income forecast for Laboratorios Farmaceuticos ROVI SA?
Projected CAGR
16%
16%
Over the last 13 years, the compound annual growth rate for Operating Income has been 18%. The projected CAGR for the next 5 years is 16%.
What is the Pre-Tax Income forecast for Laboratorios Farmaceuticos ROVI SA?
Projected CAGR
17%
17%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 18%. The projected CAGR for the next 3 years is 17%.
What is the Net Income forecast for Laboratorios Farmaceuticos ROVI SA?
Projected CAGR
15%
15%
Over the last 13 years, the compound annual growth rate for Net Income has been 16%. The projected CAGR for the next 5 years is 15%.